Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and Rho-Associated Protein Kinase-Induced Brain Changes in Vascular Dementia
Eun Chae Lee, Dong-Yong Hong, Dong-Hun Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 446-446
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Memory Enhancement with Kynurenic Acid and Its Mechanisms in Neurotransmission
Diána Martos, Bernadett Tuka, Masaru Tanaka, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 849-849
Open Access | Times Cited: 80
The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Salwa H Zekry, et al.
Neuroscience (2025)
Closed Access | Times Cited: 2
Editorial of Special Issue ‘Dissecting Neurological and Neuropsychiatric Diseases: Neurodegeneration and Neuroprotection’
Masaru Tanaka, László Vécsei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6991-6991
Open Access | Times Cited: 61
Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial
Masaru Tanaka, Ágnes Szabó, László Vécsei
Biomedicines (2022) Vol. 10, Iss. 12, pp. 2999-2999
Open Access | Times Cited: 51
From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
Masaru Tanaka, Ágnes Szabó, Tamás Körtési, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2649-2649
Open Access | Times Cited: 40
The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs on Motor Domain
Diána Martos, Bálint Lőrinczi, István Szatmári, et al.
(2024)
Open Access | Times Cited: 12
The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain
Diána Martos, Bálint Lőrinczi, István Szatmári, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3394-3394
Open Access | Times Cited: 12
The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies
Sophie Dithmer, Ingolf E. Blasig, Paul Fraser, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5601-5601
Open Access | Times Cited: 10
Memory Enhancement with Kynurenic Acid and its Mechanisms in Neurotransmission
Diána Martos, Bernadett Tuka, Masaru Tanaka, et al.
(2022)
Open Access | Times Cited: 37
Apigenin Attenuates Hippocampal Microglial Activation and Restores Cognitive Function in Methotrexate-Treated Rats: Targeting the miR-15a/ROCK-1/ERK1/2 Pathway
Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3770-3787
Open Access | Times Cited: 18
Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood–brain barrier impairment
Narek Manukjan, Daria Majcher, Peter Leenders, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study
Yujiao Wang, Daojun Xie, Shijia Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Advances in the Study of Necroptosis in Vascular Dementia: Focus on Blood–Brain Barrier and Neuroinflammation
Yuemin Qiu, Lin Cheng, Yinyi Xiong, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access
Therapeutic Approaches and Potential Mechanisms of Small Extracellular Vesicles in Treating Vascular Dementia
Yujie Yang, Chunchu Deng, Fatima Aldali, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 409-409
Open Access
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
Richard Killick, Christina Elliott, Elena M. Ribé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11219-11219
Open Access | Times Cited: 9
Effects of schisandrin B on hypoxia-related cognitive function and protein expression in vascular dementia rats
Jingbo He, He Zhang, Hongxia Zheng, et al.
Journal of Toxicology and Environmental Health (2024) Vol. 87, Iss. 10, pp. 421-427
Closed Access | Times Cited: 3
Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases
Qiuyan Ye, Xue Li, Wei Gao, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Anxiety disorders and depression are associated with resistant hypertension
Handan Duman, Hakan Duman, Meltem Puşuroğlu, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 33, Iss. 2, pp. 111-118
Open Access | Times Cited: 6
A Study of Brain Function Characteristics of Service Members at High Risk for Accidents in the Military
Sung-Oh Choi, Jong-Geun Choi, Jong-Yong Yun
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1157-1157
Open Access | Times Cited: 4
Carotid artery vascular stenosis causes the blood-CSF barrier damage and neuroinflammation
Lin Lin, Yang Chen, Kai He, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Statins for vascular dementia: A hype or hope
Haroon Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access | Times Cited: 1
ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis
Dong-Hun Lee, Ji Young Lee, Dong-Yong Hong, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1348-1348
Open Access | Times Cited: 7
Acupoint catgut embedding improves learning and memory impairment in vascular dementia rats
Shijie Zhu, Xia Li, Yuwei Wei, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 2, pp. 108-108
Open Access | Times Cited: 3
Comparative Investigation of Raw and Processed Radix Polygoni Multiflori on the Treatment of Vascular Dementia by Liquid Chromatograph−Mass Spectrometry Based Metabolomic Approach
Fengye Wu, Yunlin Li, Wenya Liu, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1297-1297
Open Access | Times Cited: 4
Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction
Yun-An Lim, Li Si Tan, Wei Thye Lee, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299703-e0299703
Open Access
Page 1 - Next Page

Scroll to top